2A Biosciences is pioneering a new class of disease-modifying therapies by unlocking the regenerative and neuroprotective power of serotonin 2A receptors. Our proprietary small molecules are designed to precisely activate 5-HT2A receptors to drive reinnervation, neuroprotection, and inflammation resolution across neurodegenerative ocular and CNS diseases. By targeting upstream biology that governs mitochondrial dysfunction, oxidative stress, and neuroinflammation, our approach simultaneously engages multiple degenerative pathways to halt disease progression at the root while promoting neuronal growth and functional repair.
Company Details
- Employees
- 9
- Founded
- -
- Address
- New York, Ny, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.2abiosci.com
- HQ
- New York, NY
2a Biosciences Questions
2A Biosciences's website is http://www.2abiosci.com
2A Biosciences's LinkedIn profile is https://www.linkedin.com/company/2abiosci
2A Biosciences has
9 employees.
View email and phone details for 9
employees at 2A Biosciences.
2A Biosciences's industry is
Biotechnology Research
2A Biosciences's top competitors are
Psychedelic Alpha,
Noetic Fund,
Sensorium Therapeutics,
Lionheart Ventures,
Xylo Bio,
Gh Research Plc,
Terran Biosciences,
Gilgamesh Pharmaceuticals,
Remind,
Atai Life Sciences.
2A Biosciences's categories are Biotechnology Research
2A Biosciences's founding year is 2023
